At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
ambu ascope +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized- Single Blind Trial of Ambu Ascope and Fiberoptic in Severely Difficult Air Way Patient Having Posterior Third Fixed Tongue Cancer
In Brief
A clinical study evaluating ambu ascope and fibreroptic bronchoscope for Difficult Intubation. Completed, enrolled 100 participants across 1 site.
Detailed Summary
This study compares the ascope with standard fiberscope using the nasal route of intubation in patient having sever difficult airway (having posterior one third cancer tongue with fixed mobility)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDifficult Intubation
CountriesEgypt
CollaboratorsCairo University
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartAug 2018
First PostedJun 2019
Primary CompletionMay 2020
Study CompletionMay 2020
TodayJul 2026
First PostedJun 26, 2019
Enrollment StartAug 1, 2018
Primary CompletionMay 5, 2020
Study CompletionMay 19, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7.0 years ago
Interventions
ambu ascopedevice
nasal route intubation by the device in fixed cancer tongue patients
fibreroptic bronchoscopedevice
nasal route intubation by the device in fixed cancer tongue patients